FOXP1: a potential therapeutic target in cancer.

FOXP1: a potential therapeutic target in cancer.

Forkhead Box P1 (FOXP1) is a member of the FOX family of transcription factors which have a broad range of functions. Foxp1 is widely expressed and has been shown to have a role in cardiac, lung and lymphocyte development. FOXP1 is targeted by recurrent chromosome translocations and its overexpressi...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Koon, H, Ippolito, G, Banham, A, Tucker, P
Formáid:	Journal article
Teanga:	English
Foilsithe / Cruthaithe:	2007

Míreanna comhchosúla

Therapeutic targeting of FOXP3-positive regulatory T cells using a FOXP3 peptide vaccine WO2008081581.
de réir: Banham, A, et al.
Foilsithe / Cruthaithe: (2009)

circFOXP1: a potential diagnostic and therapeutic target in human diseases
de réir: Qiang Yi, et al.
Foilsithe / Cruthaithe: (2024-11-01)

Identification of FOXP1 Transcriptional Targets in Diffuse Large B Cell Lymphoma
de réir: Camilleri, E, et al.
Foilsithe / Cruthaithe: (2012)

The significance of FOXP1 in diffuse large B-cell lymphoma
de réir: Gascoyne, D, et al.
Foilsithe / Cruthaithe: (2016)

The FOXP3 transcription factor as a regulatory T-cell marker
de réir: Banham, A
Foilsithe / Cruthaithe: (2008)

FOXP3+ regulatory T cells as biomarkers in human malignancies.
de réir: Bignone, P, et al.
Foilsithe / Cruthaithe: (2008)

Characterization of human FOXP1 isoform 2, using monoclonal antibody 4E3-G11, and intron retention as a tissue-specific mechanism generating a novel FOXP1 isoform.
de réir: Brown, P, et al.
Foilsithe / Cruthaithe: (2008)

Is FOXP3 expressed in cutaneous T-cell lymphomas?
de réir: Banham, A, et al.
Foilsithe / Cruthaithe: (2008)

N-terminally truncated FOXP1 protein expression and alternate internal FOXP1 promoter usage in normal and malignant B cells.
de réir: Brown, P, et al.
Foilsithe / Cruthaithe: (2016)

Monoclonal antibodies raised to the human FOXP3 protein can be used effectively for detecting Foxp3(+) T cells in other mammalian species.
de réir: Banham, A, et al.
Foilsithe / Cruthaithe: (2009)

Cell-surface IL-7 receptor expression facilitates the purification of FOXP3(+) regulatory T cells.
de réir: Banham, A
Foilsithe / Cruthaithe: (2006)

FOXP3+ regulatory T cells: Current controversies and future perspectives.
de réir: Banham, A, et al.
Foilsithe / Cruthaithe: (2006)

The presence of tumor-infiltrating FOXP3+ lymphocytes correlates with intratumoral angiogenesis in endometrial cancer.
de réir: Giatromanolaki, A, et al.
Foilsithe / Cruthaithe: (2008)

MALT1, BCL10 and FOXP1 in salivary gland mucosa-associated lymphoid tissue lymphomas.
de réir: Borovecki, A, et al.
Foilsithe / Cruthaithe: (2007)

N-terminally truncated FOXP1 protein expression and alternate internal FOXP1 promoter usage in normal and malignant B cells
de réir: Philip J. Brown, et al.
Foilsithe / Cruthaithe: (2016-07-01)

The FOXP1 transcription factor is expressed in the majority of follicular lymphomas but is rarely expressed in classical and lymphocyte predominant Hodgkin's lymphoma.
de réir: Brown, P, et al.
Foilsithe / Cruthaithe: (2005)

Immunologic targeting of FOXP3 in inflammatory breast cancer cells.
de réir: Smita Nair, et al.
Foilsithe / Cruthaithe: (2013-01-01)

Expression of FOXP2 is up-regulated in lymphoid malignancies
de réir: Campbell, A, et al.
Foilsithe / Cruthaithe: (2009)

Expression of the forkhead box transcription factor FOXP1 is associated with oestrogen receptor alpha, oestrogen receptor beta and improved survival in familial breast cancers.
de réir: Rayoo, M, et al.
Foilsithe / Cruthaithe: (2009)

Defense of the clone: antibody 259D effectively labels human FOXP3 in a variety of applications.
de réir: Fox, B, et al.
Foilsithe / Cruthaithe: (2008)

FOXP3 infiltrating lymphocyte density and PD-L1 expression in operable non-small cell lung carcinoma
de réir: Giatromanolaki, A, et al.
Foilsithe / Cruthaithe: (2019)

Therapeutic efficacy of ECs Foxp1 targeting Hif1α-Hk2 glycolysis signal to restrict angiogenesis
de réir: Jingjiang Pi, et al.
Foilsithe / Cruthaithe: (2024-09-01)

FOXP3 expression in B and T cell lymphomas.
de réir: Roncador, G, et al.
Foilsithe / Cruthaithe: (2005)

Potentially oncogenic B-cell activation-induced smaller isoforms of FOXP1 are highly expressed in the activated B cell-like subtype of DLBCL.
de réir: Brown, P, et al.
Foilsithe / Cruthaithe: (2008)

FOXP1 abnormalities in lymphoma: translocation breakpoint mapping reveals insights into deregulated transcriptional control.
de réir: Goatly, A, et al.
Foilsithe / Cruthaithe: (2008)

FOXP1 abnormalities in lymphoma: Translocation breakpoint mapping reveals insights into deregulated transcriptional control
de réir: Goatly, A, et al.
Foilsithe / Cruthaithe: (2008)

FOXP3 and Tip60 Structural Interactions Relevant to IPEX Development Lead to Potential Therapeutics to Increase FOXP3 Dependent Suppressor T Cell Functions
de réir: Payal Grover, et al.
Foilsithe / Cruthaithe: (2021-02-01)

Expression of the forkhead transcription factor FOXP1 is associated with that of estrogen receptor-beta in primary invasive breast carcinomas.
de réir: Bates, G, et al.
Foilsithe / Cruthaithe: (2008)

Expression of the forkhead transcription factor FOXP1 is associated both with hypoxia inducible factors (HIFs) and the androgen receptor in prostate cancer but is not directly regulated by androgens or hypoxia.
de réir: Banham, A, et al.
Foilsithe / Cruthaithe: (2007)

Developmental changes of FOXP3-expressing CD4+CD25+ regulatory T cells and their impairment in patients with FOXP3 gene mutations.
de réir: Fuchizawa, T, et al.
Foilsithe / Cruthaithe: (2007)

Characterization of FOXP3+CD4+ regulatory T cells in Crohn's disease.
de réir: Saruta, M, et al.
Foilsithe / Cruthaithe: (2007)

Bcl-2 but not FOXP1, is an adverse risk factor in immunochemotherapy-treated non-germinal center diffuse large B-cell lymphomas.
de réir: Nyman, H, et al.
Foilsithe / Cruthaithe: (2009)

BCL-2 but not FOXP1, is an adverse risk factor in immunochemotherapy treated non-germinal center diffuse large B-cell lymphomas
de réir: Nyman, H, et al.
Foilsithe / Cruthaithe: (2008)

Immunomodulation of FOXP3+ regulatory T cells by the aromatase inhibitor letrozole in breast cancer patients.
de réir: Generali, D, et al.
Foilsithe / Cruthaithe: (2009)

Strong expression of FOXP1 identifies a distinct subset of diffuse large B-cell lymphoma (DLBCL) patients with poor outcome.
de réir: Barrans, S, et al.
Foilsithe / Cruthaithe: (2004)

Exploring the expression of the androgen receptor (AR) in prostate cancer: Its relationship to the vascular endothelial growth factor (VEGF), hypoxia inducible factors (HIF) 1 and 2 and the novel forkhead transcription factor, FOXP1
de réir: Boddy, J, et al.
Foilsithe / Cruthaithe: (2005)

Expression of the FOXP1 transcription factor is strongly associated with inferior survival in patients with diffuse large B-cell lymphoma.
de réir: Banham, A, et al.
Foilsithe / Cruthaithe: (2005)

Expression and functional characterization of FOXP3+ CD4+ regulatory T cells in ulcerative colitis.
de réir: Yu, Q, et al.
Foilsithe / Cruthaithe: (2007)

Loss of expression and nuclear/cytoplasmic localization of the FOXP1 forkhead transcription factor are common events in early endometrial cancer: relationship with estrogen receptors and HIF-1alpha expression.
de réir: Giatromanolaki, A, et al.
Foilsithe / Cruthaithe: (2006)

Expression of the forkhead transcription factor FOXP1 is associated with estrogen receptor alpha and improved survival in primary human breast carcinomas.
de réir: Fox, S, et al.
Foilsithe / Cruthaithe: (2004)